Labetalol vs. methyldopa in the treatment of pregnancy-induced hypertension

International Journal of Gynecology and Obstetrics

Volumn 49, Issue 2, 1995, Pages 125-130

  El Qarmalawi, A M ^a   Morsy, A H ^a   Al Fadly, A ^a   Obeid, A ^a   Hashem, M ^a  

^a AL JAHRA HOSPITAL   (Kuwait)

Author keywords

Labetalol; Methyldopa; Pregnancy induced hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; LABETALOL; METHYLDOPA;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BORDERLINE HYPERTENSION; CESAREAN SECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HUMAN; LABOR INDUCTION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MEAN ARTERIAL PRESSURE; PRIMIGRAVIDA; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL;

ADULT; BLOOD PRESSURE; CESAREAN SECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPERTENSION; INFANT, NEWBORN; KUWAIT; LABETALOL; LABOR, INDUCED; METHYLDOPA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

EID: 0029045232     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/0020-7292(95)02351-C     Document Type: Article

References (22)

1. Management of pregnancy induced hypertension in the nulliparous patients remote from term
2. Labetalol in pregnancy induced hypertension: fetal and maternal effects
3. Morphological changes in the uteroplacental bed in pregnancy hypertension
4. On pathogenesis of pre-eclampsia and eclampsia
5. Preeclampsia: an endothelial cell disorder
6. Synergistic inhibitory effect of adrenoceptor antagonists and prostacyclin, and umbilical artery-derived prostacyclin-like activity on platelet aggregation
7. Nifedipine treatment in preeclampsia reverts the increased erythrocyte aggregation to normal
8. Drugs, hypertension and pregnancy
9. Final report on study on hypertension during pregnancy: the effect of specific treatment on the growth and development of the children
10. Labetalol pharmacokinetics in pregnancy-induced hypertension
11. Pharmacology of alpha-beta blockade
12. Combined alpha- and beta-receptor inhibition in the treatment of hypertension
13. Current status of labetalol, the first alphaand beta-blocking agent
14. The effect of labetalol on the contractility of human myometrial preparations
15. The evaluation of labetalol in the treatment of hypertension complicating pregnancy
16. Labetalol for the treatment of hypertension in pregnancy Pharmacokinetics and effect on the uteroplacental blood flow
17. The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension
18. Comparison of efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy a randomized controlled trial
19. The effect of maternal labetalol on the neonate
20. Cardiac arrest in newborn of mother treated with labetalol